Corvus Pharmaceuticals (CRVS) Capital Expenditures (QoQ) (2015 - 2026)
Corvus Pharmaceuticals (CRVS) Capital Expenditures (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Corvus Pharmaceuticals | 1.23 Bn | 1.23 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 118.69% |
| Dec 31, 2025 | -255.10% |
| Sep 30, 2025 | 256.22% |
| Jun 30, 2025 | -658.33% |
| Mar 31, 2025 | -95.97% |
| Dec 31, 2024 | 403.74% |
| Sep 30, 2024 | -2.44% |
| Jun 30, 2024 | -1.06% |
| Mar 31, 2023 | -86.77% |
| Dec 31, 2022 | 3,112.50% |
| Dec 31, 2021 | 478.38% |
| Sep 30, 2021 | 95.14% |
| Jun 30, 2021 | -214.76% |
| Mar 31, 2021 | 509.17% |
| Dec 31, 2020 | 619.05% |
| Dec 31, 2019 | 650.00% |
| Mar 31, 2019 | 103.88% |
| Dec 31, 2018 | -29.97% |
| Sep 30, 2018 | -345.74% |
| Jun 30, 2018 | -33.51% |